JUL 11, 2026 · JOURNAL ARTICLE
Artesunate-loaded bovine serum albumin nanoplatform with metal-polyphenol network coating for ferroptosis-driven breast cancer therapy.
International Journal of Pharmaceutics: X
Preclinical proof-of-concept in cell and animal models showing a novel nanoparticle formulation induces ferroptosis and tumor inhibition, but lacks human efficacy data, safety characterization, and direct comparator controls.
Reported
Tumor inhibition rate83.11%